Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 787

1.

Reassessment Intervals for Transition From Low to High Fracture Risk Among Adults Older Than 50 Years.

Leslie WD, Morin SN, Lix LM, Martineau P, Bryanton M, McCloskey EV, Johansson H, Harvey NC, Kanis JA.

JAMA Netw Open. 2020 Jan 3;3(1):e1918954. doi: 10.1001/jamanetworkopen.2019.18954.

PMID:
31922559
2.

Risk for hip fracture before and after total knee replacement in Sweden.

Vala CH, Kärrholm J, Kanis JA, Johansson H, Sten S, Sundh V, Karlsson M, Lorentzon M, Mellström D.

Osteoporos Int. 2019 Dec 12. doi: 10.1007/s00198-019-05241-x. [Epub ahead of print]

PMID:
31832694
3.

Increased risk for hip fracture after death of a spouse-further support for bereavement frailty?

Vala CH, Lorentzon M, Sundh V, Johansson H, Lewerin C, Sten S, Karlsson M, Ohlsson C, Johansson B, Kanis JA, Mellström D.

Osteoporos Int. 2019 Dec 12. doi: 10.1007/s00198-019-05242-w. [Epub ahead of print]

PMID:
31832693
4.

Incidence of myocardial infarction and associated mortality varies by latitude and season: findings from a Swedish Registry Study.

Harvey NC, Lorentzon M, Kanis JA, McCloskey E, Johansson H.

J Public Health (Oxf). 2019 Nov 28. pii: fdz131. doi: 10.1093/pubmed/fdz131. [Epub ahead of print]

PMID:
31774530
5.

Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures.

Kanis JA, Harvey NC, McCloskey E, Bruyère O, Veronese N, Lorentzon M, Cooper C, Rizzoli R, Adib G, Al-Daghri N, Campusano C, Chandran M, Dawson-Hughes B, Javaid K, Jiwa F, Johansson H, Lee JK, Liu E, Messina D, Mkinsi O, Pinto D, Prieto-Alhambra D, Saag K, Xia W, Zakraoui L, Reginster J-.

Osteoporos Int. 2020 Jan;31(1):1-12. doi: 10.1007/s00198-019-05176-3. Epub 2019 Nov 13.

PMID:
31720707
6.

Correction to: European guidance for the diagnosis and management of osteoporosis in postmenopausal women.

Kanis JA, Cooper C, Rizzoli R, Reginster JY; Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF).

Osteoporos Int. 2020 Jan;31(1):209. doi: 10.1007/s00198-019-05184-3.

PMID:
31673731
7.

Systematic screening using FRAX® leads to increased use of, and adherence to, anti-osteoporosis medications: an analysis of the UK SCOOP trial.

Parsons CM, Harvey N, Shepstone L, Kanis JA, Lenaghan E, Clarke S, Fordham R, Gittoes N, Harvey I, Holland R, Redmond NM, Howe A, Marshall T, Peters TJ, Torgerson D, O'Neill TW, McCloskey E, Cooper C; SCOOP Trial Group.

Osteoporos Int. 2020 Jan;31(1):67-75. doi: 10.1007/s00198-019-05142-z. Epub 2019 Oct 12.

PMID:
31606826
8.

Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis.

Lorentzon M, Branco J, Brandi ML, Bruyère O, Chapurlat R, Cooper C, Cortet B, Diez-Perez A, Ferrari S, Gasparik A, Herrmann M, Jorgensen NR, Kanis J, Kaufman JM, Laslop A, Locquet M, Matijevic R, McCloskey E, Minisola S, Pikner R, Reginster JY, Rizzoli R, Szulc P, Vlaskovska M, Cavalier E.

Adv Ther. 2019 Oct;36(10):2811-2824. doi: 10.1007/s12325-019-01063-9. Epub 2019 Aug 22.

9.

Assessing the risk of osteoporotic fractures: the Ecuadorian FRAX model.

Lopez Gavilanez E, Johansson H, McCloskey E, Harvey NC, Segale Bajana A, Marriott Blum D, Navarro Grijalva M, Diaz Curiel M, Kanis JA.

Arch Osteoporos. 2019 Aug 22;14(1):93. doi: 10.1007/s11657-019-0644-8.

PMID:
31440846
10.

Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF).

Hiligsmann M, Cornelissen D, Vrijens B, Abrahamsen B, Al-Daghri N, Biver E, Brandi ML, Bruyère O, Burlet N, Cooper C, Cortet B, Dennison E, Diez-Perez A, Gasparik A, Grosso A, Hadji P, Halbout P, Kanis JA, Kaufman JM, Laslop A, Maggi S, Rizzoli R, Thomas T, Tuzun S, Vlaskovska M, Reginster JY.

Osteoporos Int. 2019 Nov;30(11):2155-2165. doi: 10.1007/s00198-019-05104-5. Epub 2019 Aug 7.

11.

Influence of fall environment and fall direction on risk of injury among pre-frail and frail adults.

Gratza SK, Chocano-Bedoya PO, Orav EJ, Fischbacher M, Freystätter G, Theiler R, Egli A, Kressig RW, Kanis JA, Bischoff-Ferrari HA.

Osteoporos Int. 2019 Nov;30(11):2205-2215. doi: 10.1007/s00198-019-05110-7. Epub 2019 Aug 3.

PMID:
31377914
12.

East meets West: current practices and policies in the management of musculoskeletal aging.

Xia W, Cooper C, Li M, Xu L, Rizzoli R, Zhu M, Lin H, Beard J, Ding Y, Yu W, Cavalier E, Zhang Z, Kanis JA, Cheng Q, Wang Q, Reginster JY.

Aging Clin Exp Res. 2019 Oct;31(10):1351-1373. doi: 10.1007/s40520-019-01282-8. Epub 2019 Aug 2. Review.

13.

Fracture prediction from self-reported falls in routine clinical practice: a registry-based cohort study.

Leslie WD, Morin SN, Lix LM, Martineau P, Bryanton M, McCloskey EV, Johansson H, Harvey NC, Kanis JA.

Osteoporos Int. 2019 Nov;30(11):2195-2203. doi: 10.1007/s00198-019-05106-3. Epub 2019 Aug 2.

PMID:
31372711
14.

FRAX-based intervention and assessment thresholds for osteoporosis in Iran.

Khashayar P, Keshtkar A, Ostovar A, Larijani B, Johansson H, Harvey NC, Lorentzon M, McCloskey E, Kanis JA.

Osteoporos Int. 2019 Nov;30(11):2225-2230. doi: 10.1007/s00198-019-05078-4. Epub 2019 Aug 1.

PMID:
31372709
15.

Correction to: Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review.

Bauer JM, Cruz-Jentoft AJ, Fielding RA, Kanis JA, Reginster JY, Bruyère O, Cesari M, Chapurlat R, Al-Daghri N, Dennison E, Kaufman JM, Landi F, Laslop A, Locquet M, Maggi S, McCloskey E, Perna S, Rizzoli R, Rolland Y, Rondanelli M, Szulc P, Vellas B, Vlaskovska M, Cooper C.

Calcif Tissue Int. 2019 Aug;105(2):125-126. doi: 10.1007/s00223-019-00587-0.

PMID:
31338562
16.

Fracture Risk in Women with Breast Cancer Initiating Aromatase Inhibitor Therapy: A Registry-Based Cohort Study.

Leslie WD, Morin SN, Lix LM, Niraula S, McCloskey EV, Johansson H, Harvey NC, Kanis JA.

Oncologist. 2019 Nov;24(11):1432-1438. doi: 10.1634/theoncologist.2019-0149. Epub 2019 Jul 10.

17.

Temporal changes in access to FRAX® in Thailand between 2010 and 2018.

Chotiyarnwong P, Harvey NC, Johansson H, Liu E, Lorentzen M, Kanis JA, McCloskey EV.

Arch Osteoporos. 2019 Jun 21;14(1):66. doi: 10.1007/s11657-019-0613-2.

18.

Fracture risk following intermission of osteoporosis therapy.

Dennison EM, Cooper C, Kanis JA, Bruyère O, Silverman S, McCloskey E, Abrahamsen B, Prieto-Alhambra D, Ferrari S; IOF Epidemiology/Quality of Life Working Group.

Osteoporos Int. 2019 Sep;30(9):1733-1743. doi: 10.1007/s00198-019-05002-w. Epub 2019 Jun 7.

PMID:
31175404
19.

Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review.

Bauer JM, Cruz-Jentoft AJ, Fielding RA, Kanis JA, Reginster JY, Bruyère O, Cesari M, Chapurlat R, Al-Daghri N, Dennison E, Kaufman JM, Landi F, Laslop A, Locquet M, Maggi S, McCloskey E, Perna S, Rizzoli R, Rolland Y, Rondanelli M, Szulc P, Vellas B, Vlaskovska M, Cooper C.

Calcif Tissue Int. 2019 Aug;105(2):109-124. doi: 10.1007/s00223-019-00561-w. Epub 2019 May 16. Review. Erratum in: Calcif Tissue Int. 2019 Jul 23;:.

PMID:
31098729
20.

A multicenter study to evaluate harmonization of assays for N-terminal propeptide of type I procollagen (PINP): a report from the IFCC-IOF Joint Committee for Bone Metabolism.

Cavalier E, Eastell R, Rye Jørgensen N, Makris K, Tournis S, Vasikaran S, Kanis JA, Cooper C, Pottel H, Morris HA; IFCC-IOF Joint Committee for Bone Metabolism (C-BM).

Clin Chem Lab Med. 2019 Sep 25;57(10):1546-1555. doi: 10.1515/cclm-2019-0174.

PMID:
31085740

Supplemental Content

Loading ...
Support Center